Choosing an EU Authorised Representative under MDR and IVDR
A manufacturer of medical devices or in vitro diagnostics that has no registered place of business in the European Union cannot place a device on the EU market until it has designated a single authorised representative (often labelled EC REP on device labels). Article 11 of the Medical Device Regulation (EU) 2017/745 and Article 11 of the In Vitro Diagnostic Regulation (EU) 2017/746 turned this role from a mailbox function into a legally accountable one: the authorised representative is jointly and severally liable with the manufacturer for defective devices if the manufacturer has not complied with its own obligations.
What the authorised representative must do
- Verify that the EU declaration of conformity and technical documentation have been drawn up and that the conformity assessment procedure has been carried out.
- Keep available a copy of the technical documentation, the declaration of conformity and any notified body certificate for competent authorities.
- Register in EUDAMED and verify the manufacturer's registration obligations, including UDI data.
- Cooperate with competent authorities on preventive or corrective action, and forward complaints and incident reports to the manufacturer.
- Terminate the mandate if the manufacturer acts contrary to its obligations, and inform the competent authority and notified body.
- Have permanently and continuously at its disposal a person responsible for regulatory compliance (PRRC) under Article 15.
Single registration numbers and EUDAMED
Every authorised representative registers as an economic operator in the EUDAMED actor registration module and receives a Single Registration Number (SRN) in the format CC-AR-000000000, where the country code reflects the member state of establishment. The SRN appears on documentation and is the cleanest way to confirm that a provider is a registered actor rather than a consultancy that subcontracts the mandate. The EUDAMED public interface returns registered actors one record at a time, so comparing providers across countries means reconciling many individual entries.
How providers differ
| Criterion | Why it matters |
|---|---|
| Member state of establishment | Determines the supervising competent authority and the language of correspondence with it. |
| MDR, IVDR or both | IVDR mandates for Class C and D devices require specific performance evaluation expertise. |
| Other representation roles | Many providers also act as UK Responsible Person, Swiss CH-REP (required since the end of the EU-Swiss MRA for devices) or US Agent, which simplifies multi-market launches. |
| Liability cover | Joint liability under Article 11(5) means insurers and contract terms on indemnity matter. |
| Quality system | ISO 13485 certification of the representative itself signals documented processes for vigilance and document control. |
Changing authorised representative
Article 12 MDR sets out the change procedure: a written agreement between the manufacturer, the outgoing representative and, where practicable, the incoming one, covering the date the mandate ends, the transfer of documents, and the handling of labels and complaints. Labels and IFUs must be updated, and the change must be reflected in EUDAMED. Because labelling changes are costly, manufacturers tend to compare providers carefully before the first CE marking rather than switching later.
Fees are typically charged as an annual retainer per manufacturer, often tiered by device class and number of products; Class III and Class D portfolios usually carry higher fees because of the documentation review and vigilance workload.